Share Buyback of Restricted Stock Compensation｜July 2026

Summary of Disposal

Showei Pharmaceutical, as part of its restricted stock compensation system, disposed of 7,500 shares of treasury stock to three targeted directors, raising a total of 12,412,500 yen. The payment price per share is 1,655 yen, based on the market stock price. The disposal is scheduled for August 17, 2026, aiming to minimize shareholder stock dilution and to incentivize directors. The system includes provisions for a restricted transfer period and conditions for解除, contingent on continuous service by directors. This initiative seeks to enhance long-term corporate value.

Impact on Shareholders and Future Outlook

This disposal of treasury stock aims to minimize shareholder dilution while reinforcing directors' commitment to increasing corporate value. The funds raised will likely be used for future business investments and growth strategies. The system is designed to align incentives and share value with shareholders, contributing to long-term improvement in corporate value. Continuous monitoring of system implementation and its impact on performance remains essential.